Vai al contenuto principale Vai alla ricerca

Pubblicazioni

2018


Schmidt A, Fleischmann A, Lorez M, Rohrmann S, and the NICER Working Group. Incidence and mortality trends of gastric cancer in Switzerland 1988-2014. Schweizer Krebsbulletin Nr. 4/2018. Dati del Registro Tumori Canton Ticino inclusi.
Feller A, Schmidlin K, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Konzelmann I, Maspoli M, Wanner M, Zwahlen M, Clough-Gorr K.M. Socioeconomic and demographic inequalities in stage at diagnosis and survival among colorectal cancer patients. evidence from a Swiss population-based study. Cancer Med. 2018 Apr;7(4):1498-1510.

2017


Spitale A, Ortelli L, Mazzucchelli L, Bordoni A. Quality indicators of colorectal cancer care in southern Switzerland: results from a population-based study. Swiss Med Wkly. 2017;147:w14530.
Launoy G, Bossard N, Castro C, Manfredi S and the GRELL EUROCARE-5 Working Group. Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study: S24-S31. Dati del Registro Tumori Canton Ticino inclusi.
Glória L, Bossard N, Bouvier AN, Mayer-da-Silva A, Faivre J, Miranda A and the GRELL EUROCARE-5 Working Group. Trends in net survival from stomach cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study: S32-S39. Dati del Registro Tumori Canton Ticino inclusi.
Faivre J, Bossard N, Jooste V and the GRELL EUROCARE-5 Working Group. Trends in net survival from colon cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study: S40-S47. Dati del Registro Tumori Canton Ticino inclusi.
Lepage C, Bossard N, Dejardin O, Carmona-Garcia, MC, Manfredi S, Faivre J and the GRELL EUROCARE-5 Working Group. Trends in net survival from rectal cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study: S48-S55. Dati del Registro Tumori Canton Ticino inclusi.
Ferretti S, Bossard N, Binder-Fouchard F, Faivre J, Bordoni A, Biavati P, Frassoldati A and the GRELL EUROCARE-5 Working Group. Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study: S56-S62.
Bouvier AM, Bossard N, Colonna M, Garcia-Velasco A, Carulla M, Manfredi S and the GRELL EUROCARE-5 Working Group. Trends in net survival from pancreatic cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study: S63-S69. Dati del Registro Tumori Canton Ticino inclusi.

2015


Feller A, Fehr M, Bordoni A, Bouchardy C, Frick H, Mousavi M, Steiner A, Arndt V, Clogh-Gorr KM and the NICER Working Group. Trends in incidence of oesophageal and gastric cancer according to morphology and anatomical location, in Switzerland 1982-2011 Swiss Med Wkly. 2015;145:w14245.

2014


Ruhstaller T, Arndt V, Lorez M and the NICER Working Group. Trends in survival from oesophageal cancer in Switzerland. Bulletin Suisse Cancer Nr 3/2014:227-231. Dati del Registro Tumori Canton Ticino inclusi.

2013


Martin V, Landi L,  Molinari F,  Fountzilas G, Geva R, Riva A, Saletti P, De Dosso S, Spitale A, Tejpar S, Kalogeras K T, Mazzucchelli L, Frattini M and Cappuzzo F.
HER2 gene copy number status may influence clinical efficacy to anti-EGFR monoclonal antibodies in metastatic colorectal cancer patients. BJC 2013 (108): 668-675.
Bianchi V, Spitale A, Ortelli L, et al. Quality indicators of Clinical Cancer Care (QC3) in colorectal cancer. BMJ Open 2013;3:e002818. doi:10.1136/bmjopen-2013-002818

2012


Spitale A, Franzetti-Pellanda A, Mazzola P, Richetti A, Mazzuchelli L, Bordoni A.
Impact of preoperative radiotherapy on survival in locally advanced rectal cancer: an observational population-based study from the South of Switzerland. Eur J Cancer Prev. 2012 Mar;21(2):139-46.
Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, Nilsson B, Cirilli C, Braconi C, Bordoni A, Magnusson MK, Linke Z, Sufliarsky J, Federico M, Jonasson JG, Dei Tos AP, Rutkowski P.
Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012 Mar;13(3):265-74.
Miranda C, Nucifora M, Molinari F, Conca E, Anania MC, Bordoni A, Saletti P, Mazzucchelli L, Pilotti S, Pierotti MA, Tamborini E, Greco A, Frattini M.
KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors. Clin Cancer Res 2012;18:1769-1776.
Bordoni A, Lorez M, Bouchardy C, Konzelmann I, Clough-Gorr K and the NICER Working Group.
Trends in colorectal cancer survival in Switzerland. Bulletin Suisse Cancer, Nr.1/2012: 51-54.
Gavin AT, Francisci S, Foschi R, Donnelly DW, Lemmens V, Brenner H, Anderson LA; EUROCARE-4 Working Group.
Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012 Dec;36(6):505-12. Dati del Registro Tumori Canton Ticino inclusi.
Faivre J, Trama A, De Angelis R, Elferink M, Siesling S, Audisio R, Bosset JF, Cervantes A, Lepage C; RARECARE Working Group.
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002. Eur J Cancer. 2012 Jul;48(10):1417-24. Dati del Registro Tumori Canton Ticino inclusi.

2011


Bianchi Galdi V, Spitale A, Bordoni A.
Indicatori di qualità nelle cure oncologiche: studio QC3. Tribuna Medica Ticinese. Sezione Scientifica. Febbraio 2011(76):51-5.
Molinari F, Felicioni L, Buscarino M, De Dosso S, Buttitta F, Malatesta S, Movilia A, Luoni M, Boldorini R, Alabiso O, Girlando S, Soini B, Spitale A, Di Nicolantonio F, Saletti P, Crippa S, Mazzucchelli L, Marchetti A, Bardelli A, Frattini M.
Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.
Clin Cancer Res. 2011 Jul 15;17(14):4901-14. Epub 2011 Jun 1.

2009


Spitale A, Mazzucchelli L, Bordoni A.
Indicatori di qualità nel trattamento del carcinoma colorettale in Ticino. Importanza della raccolta di un numero adeguato di linfonodi. Tribuna Medica Ticinese. Sezione Scientifica. Novembre 2009(74):391-5.
Guerra A, Gertsch P.
La chirurgia del cancro dell'esofago. Tribuna Medica Ticinese. Sezione Scientifica. Luglio/agosto 2009(74):263-71. Dati del Registro Tumori Canton Ticino inclusi.
Molinari F, Martin V, Saletti P, Spitale A, Camponovo A, Bordoni A, Crippa S, Mazzucchelli L, Frattini M.
Differing deregulation of EGFR and downstream proteins in primary colorectal cancer and related metastatic sites may be clinically relevant. Br J Cancer. 2009 Apr 7;100(7):1087-94. Epub 2009 Mar 17.

2008


Ceruti S, Calderoni A, Lacina T, Mazzucchelli L, Mazzola , Bordoni A, Cerny A. Carcinoma epatocellulare. Tribuna Medica Ticinese. Sezione Scientifica. Dicembre 2008(73):527-33.
Clifford GM, Rickenbach M, Polesel J, Dal Maso L, Steffen I, Ledergerber B, Rauch A, Probst-Hensch NM, Bouchardy C, Levi F, Franceschi S; Swiss HIV Cohort.
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS. 2008;22(16):2135-41. Dati del Registro Tumori Canton Ticino inclusi.
Mazzola P, Spitale A, Banfi S, Mazzucchelli L, Frattini M, Bordoni A.
Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999-2005. Histol Histopathol 2008 Nov;23(11):1379-86.

2007


NICER and Swiss Cancer Registries.
Cancer of gallbladder and extrahepatic bile ducts in Switzerland. SKB/BSC(27)-Nr.4-07:307. Dati del Registro Tumori ori Canton Ticino inclusi.
NICER and Swiss Cancer Registries.
Cancer of liver and intrahepatic bile ducts cancer in Switzerland. SKB/BSC(27)- Nr.4-07:306. Dati del Registro Tumori Canton Ticino inclusi.
NICER and Swiss Cancer Registries.
Cancer of stomach in Switzerland. SKB/BSC(27)-Nr.1-07:41. Dati del Registro Tumori Canton Ticino inclusi.
Mazzola P, Spitale A, Frattini M, Soldini D, Bordoni A, Mazzucchelli L.
I tumori stromali gastro-intestinali (GIST) in Canton Ticino, 1999-2005: definizioni, epidemiologia, patologia e biologia molecolare. Tribuna Medica Ticinese. Sezione Scientifica. Novembre 2007(72):427-31.

2006


Lutz JM, Pury P, Raymond L et l'ensemble des Registres des tumeurs suisses.
Hétérogénéité du risque de cancer de l'estomac en Suisse: la diversité régionale de la consommation alimentaire peut-elleexpliquer les différences observées entre les contons? Bulletin Suisse du Cancer. 2006:274-7. Dati del Registro Tumori Canton Ticino inclusi.

Relazioni e poster

2017


Ortelli L, Mazzola P, Peverelli S, Bordoni A, Spitale A. 5-year recurrence rate and disease-free survival for colorectal cancer in Canton Ticino, Switzerland, 2005-2010. IACR annual conference. Utrecht, 17-19 October 2017.
Feller A, Schmidlin K, Bordoni A, Bouchardy C, Bulliard JL, Camey B, Konzelmann I, Maspoli M, Clough-Gorr K. The impact of socioeconomic position on stage at diagnosis and survival in colorectal cancer patients in Switzerland. IACR annual conference. Utrecht, 17-19 October 2017.
Ortelli L, Mazzola P, Peverelli S, Bordoni A, Spitale A. 5-year recurrence rate and disease-free survival for colorectal cancer in Canton Ticino, Switzerland, 2005-2010. 42ème Réunion du GRELL. Bruxelles, 24-26 May 2017.
Ortelli L, Mazzola P, Peverelli S, Spitale A, Bordoni A. Probabilità di recidiva a 5 anni dei tumori colo-rettali in Ticino, 2005-2016. 7a Giornata della Ricerca Clinica della Svizzera Italiana. Lugano, 10 marzo 2017.

2014


Spitale A, Ortelli L, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A and the QC3 Colorectal Cancer Working Group. Quality indicators of colorectal cancer care in canton Ticino, Switzerland: diagnosis, pathology and treatment: the QC3 study. XXXIX Réunion du GRELL. Geneva, 28-30 May 2014.

2013


Bianchi Galdi V, Franzetti-Pellanda A, Spitale A, Valli M.C., Ortelli L, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A. Quality Indicators in Radiation Therapy for Rectal Cancer: a population-based study in Southern Switzerland. 2nd ESTRO Forum. Geneva, 19-23 April 2013.
Ortelli L, Bianchi Galdi V, Mazzola P, Peverelli S, Mazzucchelli L, Bordoni A, Spitale A, Working Group dei tumori colo-rettali. Indicatori di qualità delle cure per i tumori colo-rettali: risultati e valutazioni per il Ticino dal 2011 al 2012. Terza Giornata della Ricerca Clinica della Svizzera Italiana. Lugano, 22 marzo 2013.

2012


Bianchi Galdi V, Spitale A, Mazzucchelli L, Mazzola P, Peverelli S, Bordoni A. QC3: Qualità delle Cure Contro il Cancro in Canton Ticino. Seconda Giornata della ricerca clinica della Svizzera Italiana. Lugano, 23 marzo 2012.
Bianchi Galdi V, Spitale A, Mazzucchelli L, Bordoni A. Quality indicators of Clinical Cancer Care (QC3) in the territory of Canton Ticino: preliminary results in colorectal cancer. 78th SGPath Annual Meeting. St. Gallen, 8-10 November 2012.
Bordoni A, Bianchi Galdi V,Mazzucchelli L, Spitale A. Population-based Quality Indicators of Cancer Care: the QC3 pilot study on colorectal cancer patients. SAKK Symposium. Bern, 1 november 2012.
Bordoni A, Spitale A, Mazzucchelli L, Bianchi Galdi V. QC3: Quality of Comprehensive Cancer Care in southern Switzerland. XXXIV IACR meeting. Cork, 17-19 september 2012.
Bordoni A, Spitale A, Mazzucchelli L, Bianchi Galdi V. Qualità delle Cure Contro il Cancro (QC3) nel territorio della Svizzera Italiana: risultati preliminari dei tumori colo-rettali incidenti nel 2011. XXXVII Réunion du GRELL. Porto, 16-18 mai 2012.

2011


Nucifora M, Mirando C, Molinari F, Conca E, Anania M.C, Bordoni A, Saletti P, Mazzucchelli L, Pilotti S, Pierotti M.A, Tamborini E, Greco A, Frattini M. KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors (GIST). 77th SGPath Annual Meeting. Luzern, 10-12 November 2011.
Curcio E, Molinari F, Romanelli D, Zanellato E, Bordoni A, Crippa S, Martin V, Mazzuchelli L, Frattini M. Characterization of  MYC and MNT in colorectal cancer patients. 77th SGPath Annual Meeting. Luzern, 10-12 November 2011.
Bianchi Galdi V, Spitale A, MazzucchelliL, Bordoni A. QC3 study: indicators of quality of cancer care in Southern Switzerland. 77th SGPath Annual Meeting. Luzern, 10-12 November.
Bianchi-Galdi V, Spitale A, Mazzucchelli L, Bordoni A and the QC3 Working Group.
QC3 study: indicators of quality of cancer care in Southern Switzerland. XXXVI Riunione del GRELL. Caen, 1-3 giugno 2011.

2009


Nucifora M, Molinari F, Mazzola P, Bordoni A, Crippa S, Mazzucchelli L, Frattini M.
K-Ras and BRAF mutations in gastrointestinal stromal tumors (GIST): clinical implications. LXXV Riunione Annuale della Società di Patologia. Locarno, 5-7 novembre 2009. Poster
Zanellato E, Molinari F, Martin V, Bordoni A, Franzetti-Pellanda A, Saletti P, Crippa S, Mazzucchelli L, Frattini M.
Analysis of EGFR gene deregulation and PIK3CA mutations in patients with squamous cell anal cancer (SCAC) treated with concurrent chemoradiation. LXXV Riunione Annuale della Società di Patologia. Locarno, 5-7 novembre 2009. Poster
Nucifora M, Molinari F, Banfi S, Ghisletta M, Mazzola P,Bordoni A, Crippa S, Mazzucchelli L, Frattini M.
K-Ras mutations in gastrointestinal stromal tumours (GIST): clinical implications. XXXIV Riunione del GRELL. Lugano, 20-22 maggio 2009.
Mazzucchelli L, Spitale A, Bordoni A.
Significato del numero di linfonodi nel carcinoma del colon. Dipartimento di Chirurgia EOC. Locarno, 02 febbraio 2009.

2008


Franzelli-Pellanda A, Marra G, Saletti P, Spitale A, Bordoni A, Ciernik I, Mazzucchelli L.
MGMT and MLH1 expression in rectal cancers of patients treated with preoperative chemo-radiation: predictive and prognostic significance. Scientific Association of Swiss Radiation Oncology (SASRO). Lausanne, 10-12 april 2008.
Spitale A, Mazzola P, Franzetti A, Mazzucchelli L, Bordoni A.
Neo-adjuvant radiotherapy in locally advanced rectal cancers:a population-based observation from Ticino Cancer Registry (South of Switzerland). XXXIII Riunione del GRELL. Parma, 30 aprile - 2 maggio 2008.
Mazzola P,Spitale A, Franzetti A, Mazzucchelli L, Bordoni A.
Descriptive epidemiology of rectal cancer: a population-based study from Ticino Cancer registry (South of Switzerland), 1996-2007. XXXIII Riunione del GRELL. Parma, 30 aprile - 2 maggio 2008.
Franzelli-Pellanda A, Marra G, Saletti P, Spitale A, Bordoni A, Ciernik I, Mazzucchelli L.
06-methylguanine-DNA methyltransferase (MGMT) expression in patients with locally advanced rectal cancer.
Molinari F, Martin V, Bordoni A, Crippa S, Saletti P, Mazzucchelli L, Frattini M.
Analysis of epidermal growth factor receptor (EGFR) downstream proteins in metastatic colorectal cancer patients: comparison between primary tumor and related metastatic sites. USGEB Annual Meeting. Lausanne, 6-7 febbraio 2008.

2007


Mazzola P,Spitale A, Frattini M, Mazzucchelli L, Bordoni A.
Epidemiology and molecular biology of gastrointestinal stromal tumors. Preliminay results of a population-based study, Ticino (Switzerland), 1999-2005. XXIX IACR Annual Meeting Ljubljana, 18-20 settembre 2007.
Incidenza del tumore dello stomaco in Svizzera per periodo di diagnosi e area linguistica. Dati elaborati dall'ASRT.

2006


Mazzola P, Bordoni A, Pury P, Frattini M, Camponovo A, Ghisletta M, Mazzucchelli L.
Tumori stromali gastrointestinali (GIST) in Ticino, 1996-2005. XXXI Reunion GRELL. Palma de Mallorca, 24-26 maggio 2006.

2005


Lutz JM, Pury P, Bordoni A, Gree J.
Hétérogénéité du risque de cancer de l'estomac en Suisse: association avec les différences culturelles alimentaires regionales. XXX Reunion GRELL. Lisbona, 04-06 maggio 2005. Presentazione orale

Formazione

2011


Epatocarcinoma in Ticino, giornata nazionale del fegato, Manno, 22 settembre 2011

2009


Cerny A, Bordoni A.
Malattie epatiche: numeri in espansione? Clinical Happy Hour - Colloquio mensile. Conservatorio della Svizzera Italiana, Centro San Carlo, Bellinzona, 26 novembre 2009.

2007


Spitale A, Borsari A, Mazzola P, Bordoni A.
Epidemiologia dei tumori gastro-intestinali (GIST). I tumori gastro-intestinali. Hotel Parco Paradiso, Lugano, 07 marzo 2007.